For a patient with serum sodium of 128 mmol/L (hyponatremia), what medication(s) and dosing should be started to treat depression, anxiety, and PTSD?

Mirtazapine is the safest antidepressant to start in a patient with hyponatremia (sodium 128 mmol/L)

For depression, anxiety, and PTSD in a patient with existing hyponatremia (Na 128 mmol/L), start mirtazapine 15 mg at bedtime, as it does not worsen hyponatremia, unlike SSRIs and SNRIs which significantly decrease serum sodium levels.

Why Mirtazapine is the Clear Choice

The most recent high-quality evidence demonstrates that mirtazapine uniquely does not cause hyponatremia. A 2022 triangulation study showed that mirtazapine caused no decrease in serum sodium (+0.55 ± 0.47 mmol/L, P = 0.24), while SSRIs decreased sodium by -1.00 mmol/L (P < 0.001) and SNRIs by -1.01 mmol/L (P = 0.0013) 1. This difference is explained by mirtazapine's lower binding affinity for serotonin transporter (SERT), which is directly correlated with sodium-lowering effects 1.

Dosing Protocol for Mirtazapine

• Starting dose: 15 mg orally at bedtime
• Titration: Increase to 30 mg after 1-2 weeks if tolerated and clinically indicated
• Target dose: 30-45 mg at bedtime for depression, anxiety, and PTSD
• Maximum dose: 45 mg daily

Why This Dosing Strategy

Mirtazapine has dual benefits here: it treats depression, anxiety, and PTSD while avoiding worsening hyponatremia. The sedating effects at lower doses (15 mg) can help with anxiety and sleep disturbances common in PTSD, while higher doses (30-45 mg) provide stronger antidepressant effects through increased noradrenergic activity.

Critical Management Steps for the Hyponatremia

Before starting any antidepressant, you must address the hyponatremia itself (Na 128 mmol/L):

Immediate Assessment Required

1. Determine volume status clinically: Check for orthostatic hypotension, skin turgor, mucous membranes, jugular venous pressure
2. Order labs: Serum osmolality, urine sodium, urine osmolality, TSH, cortisol (8 AM), creatinine
3. Review all medications: Diuretics, laxatives, other psychotropics that could contribute 2
4. Rule out infection: Consider diagnostic workup if any signs of acute illness 2

Hyponatremia Treatment (Concurrent with Antidepressant)

Since Na is 128 mmol/L (mild-moderate, likely asymptomatic):

• Fluid restriction: Limit to 1-1.5 L daily 2, 3
• Sodium restriction: Dietary sodium restriction 2
• Hold or reduce diuretics if patient is on them 2
• Monitor sodium: Check every 2-3 days initially, then weekly once stable 4

Do NOT use SSRIs or SNRIs - they will worsen the hyponatremia through SIADH-like mechanisms 1, 5, 6.

Alternative Antidepressants (If Mirtazapine Fails or Is Contraindicated)

If mirtazapine is not tolerated or effective:

Second-line: Fluvoxamine or Milnacipran

The same 2022 study found these agents less likely to cause hyponatremia 1:

• Fluvoxamine: 50 mg daily, increase to 100-300 mg daily (showed +0.74 mmol/L change, P = 0.33)
• Milnacipran: 12.5 mg twice daily, increase to 50 mg twice daily (showed +0.08 mmol/L change, P = 0.93)

However, these still carry some risk and require closer sodium monitoring than mirtazapine.

Avoid Completely

• Fluoxetine: Highest risk for severe hyponatremia and SIADH 5, 6
• Paroxetine, sertraline, citalopram, escitalopram: All SSRIs significantly lower sodium 1
• Venlafaxine, duloxetine, desvenlafaxine: All SNRIs significantly lower sodium 1
• Tricyclic antidepressants: Associated with hyponatremia risk 6

Monitoring Protocol

Week 1-4 (Intensive Phase)

• Check serum sodium every 3-4 days
• Monitor for symptoms: confusion, nausea, headache, seizures
• Assess antidepressant response and side effects

Week 4-12 (Stabilization Phase)

• Check sodium weekly
• Titrate mirtazapine dose based on clinical response
• Monitor weight (mirtazapine can increase appetite)

Beyond 12 Weeks

• Check sodium monthly for 3 months, then every 3 months
• Continue psychiatric symptom monitoring

Common Pitfalls to Avoid

1. Starting an SSRI/SNRI because they're "first-line" - This is dangerous in hyponatremia and will worsen sodium levels 1, 5

2. Ignoring the underlying cause of hyponatremia - Must identify if this is SIADH, volume depletion, medication-induced, or other etiology before proceeding 2

3. Rapid correction if sodium drops further - Never correct >8-10 mmol/L in 24 hours to avoid osmotic demyelination syndrome 7

4. Assuming age alone is the risk factor - Medications and comorbidities matter more than age for hyponatremia risk 6

5. Using vaptans (tolvaptan) in outpatient setting - These are reserved for severe refractory cases in hospital settings due to risk of overcorrection 2, 3

When to Hospitalize

Admit the patient if:

• Sodium drops below 120 mmol/L 2
• Any neurological symptoms develop (confusion, seizures, altered mental status) 7
• Rapid decline in sodium (>5 mmol/L in 24 hours)
• Unable to maintain fluid restriction outpatient

Evidence Quality Note

The 2022 pharmacodynamic study 1 provides the strongest, most recent evidence specifically comparing antidepressants' effects on sodium levels in elderly patients. This triangulated retrospective cohort data, pharmacovigilance reports, and mechanistic pharmacology to identify mirtazapine as uniquely safe. The WHO guidelines 8 support psychological interventions for depression/anxiety/PTSD but do not address the hyponatremia complication specifically, making the pharmacological choice critical here.